Prospective randomized open-label multicenter phase I/II dose escalation trial of visilizumab (HuM291) in severe steroid-refractory ulcerative colitis
Daniel C. Baumgart; Stephan R. Targan; Axel U. Dignass; Lloyd Mayer; Gert van Assche; Daan W. Hommes; Stephen B. Hanauer; Uma Mahadevan; Walter Reinisch; Scott E. Plevy; Bruce A. Salzberg; Alan L. Buchman; Grigor M. Mechkov; Zahariy A. Krastev; James N. Lowder; Matthew B. Frankel; William J. Sandborn
- 作者Daniel C. Baumgart; Stephan R. Targan; Axel U. Dignass; Lloyd Mayer; Gert van Assche; Daan W. Hommes; Stephen B. Hanauer; Uma Mahadevan; Walter Reinisch; Scott E. Plevy; Bruce A. Salzberg; Alan L. Buchman; Grigor M. Mechkov; Zahariy A. Krastev; James N. Lowder; Matthew B. Frankel; William J. Sandborn
- 卷第16卷
- 期第4期
- 印刷ISSN1536-4844
- 文件大小231.77KB
- 发表时间2010
- DOI10.1002/ibd.21084